Learning
WHAT’S NEW
In part one of a series of articles on ibogaine clinics, researcher Leonard Pickard looks at the history and treatment protocols o...
Underscoring an anecdotal observation common among cannabis consumers, a group of researchers in Canada have released a new study ...
The Drug Enforcement Administration (DEA) last week proposed increasing its 2024 production quotas for research-grade psychedelic ...
POPULAR ARTICLES
An Ambitious Vision Drives Kentucky’s Ibogaine Plan to Treat Opioid Dependency
A Kentucky commission will soon vote on whether to commit $42 million toward a psychedelic-assisted therapy moonshot that could tr...
Read More
Tripping Through Time: Psychedelic Art Through the Ages
How much of human art has been inspired by psychedelics? We explore psychedelic art through the ages, and humanity’s relatio...
Read More
Why the push to decriminalize psychedelics is growing in Michigan
Detroit voters will vote on whether to decriminalize entheogenic plants and fungi, including psilocybin mushrooms, which show prom...
Read More
Psychedelics, Therapy, and the Law
Today\'s guest post is by Lincoln Stoller, PhD, CHt, a hypnotherapist in British Columbia who writes at mindstrengthbalance.com. T...
Read More
Psychedelics: Can they solve the ‘hard problem’ of consciousness? | Matthew Johnson
Can psychedelics solve the ‘hard problem’ of consciousness? Johns Hopkins professor Matthew Johnson explains....
Read More
Psyched: Compass Joins Nasdaq, Field Trip Goes Public, MindMed Begins Trials, ATAI Launches MDMA Subsidiary
Compass Pathways Files for an IPO at NASDAQ UK-based Compass Pathways wants to become the first psychedelics company to ...
Read More